AbbVie: all 2,241 studies
Page 19 of 23. Open to participants first (134), then studies with results posted, then the rest; newest registration first within each.
- Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive BladderCompletedNCT02673047
- A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal AtrophyCompletedNCT02670785Phase 2
- A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K InhibitorWithdrawnNCT02640833Phase 1
- Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female SubjectsCompletedNCT02634437Phase 1
- Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1CompletedNCT02629172
- Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's DiseaseCompletedNCT02611713
- [11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple SclerosisTerminatedNCT02606630Phase 1
- A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple SclerosisCompletedNCT02601885Phase 1
- A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean PatientsCompletedNCT02601287Phase 4
- Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory LymphomaCompletedNCT02598570Phase 1
- Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male VolunteersCompletedNCT02596217Phase 1
- Diafert for Embryo Selection and Fertility Improvement (DESTINy)CompletedNCT02593513Phase 3
- Diafert® for Embryo Selection and Fertility ImprovementCompletedNCT02593461Phase 3
- Study Evaluating ABT-414 in Japanese Subjects With Malignant GliomaCompletedNCT02590263Phase 1/2
- A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in IndiaCompletedNCT02590250
- Diafert for Embryo Selection and Fertility ImprovementCompletedNCT02586272Phase 3
- informCLL™: A Disease Registry for Patients With Chronic Lymphocytic LeukemiaCompletedNCT02582879
- The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese SubjectsCompletedNCT02581020
- A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine FibroidsCompletedNCT02580578
- Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive ImpairmentTerminatedNCT02573740Phase 1
- Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNCT02571712Phase 4
- ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid TumorsCompletedNCT02565758Phase 1
- A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and JawCompletedNCT02559908Not applicable
- A Safety and Efficacy Study of JUVÉDERM® VOLIFT® With Lidocaine and Restylane® for Nasolabial Folds in Chinese AdultsCompletedNCT02558283Not applicable
- Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive BladderCompletedNCT02557971
- Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in KoreaCompletedNCT02555761
- An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic PatientsCompletedNCT02555709Phase 1/2
- Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian CancerTerminatedNCT02539719Phase 1
- Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese SubjectsCompletedNCT02534870Phase 1
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid ArthritisCompletedNCT02531178Phase 1
- Impact of Adalimumab on Patient-reported Outcomes in Ulcerative ColitisCompletedNCT02506179
- Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in JapanCompletedNCT02505776
- Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®CompletedNCT02502123
- SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine CarcinomaTerminatedNCT02500914Phase 1
- Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated PatientsCompletedNCT02485600
- Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian CancerCompletedNCT02483104Phase 1
- Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple MyelomaTerminatedNCT02462525Phase 1
- Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal FunctionCompletedNCT02442258Phase 1
- Retrospective Study of Reoperation After Primary Augmentation With NATRELLE® INSPIRA® Breast ImplantsCompletedNCT02438332
- Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07CompletedNCT02434666Phase 2
- A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197TerminatedNCT02429895Phase 2
- Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry EyeCompletedNCT02420730Phase 1
- Perception of Facial Expression in Subjects With and Without Crow's Feet LinesCompletedNCT02417077
- A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With CancerCompletedNCT02391480Phase 1
- Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral TherapyCompletedNCT02381444
- Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy VolunteersCompletedNCT02366364Phase 1
- A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorTerminatedNCT02365662Phase 1
- Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid ArthritisCompletedNCT02362074
- A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02348476
- Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in CombinationCompletedNCT02342067Phase 1
- Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRAWithdrawnNCT02322723
- Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic FunctionCompletedNCT02296905Phase 1
- An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral AdministrationCompletedNCT02274181Phase 1
- A P3 Comparator Trial in Community Acquired Bacterial PneumoniaWithdrawnNCT02269644Phase 3
- Study Evaluating Venetoclax in Subjects With Hematological MalignanciesCompletedNCT02265731Phase 1/2
- Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in KoreaCompletedNCT02248844
- A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and BlepharospasmCompletedNCT02245958
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsTerminatedNCT02220738Phase 1
- A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide TherapeuticallyCompletedNCT02220348Phase 1
- Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne VulgarisCompletedNCT02218034Phase 1
- A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid TumorsCompletedNCT02210663Phase 1
- Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)TerminatedNCT02203773Phase 1
- Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary HyperhidrosisCompletedNCT02193139Phase 2
- An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)CompletedNCT02188173
- A Study of Abicipar Pegol in Patients With Diabetic Macular EdemaCompletedNCT02186119Phase 2
- An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of AndroxalCompletedNCT02169804Phase 1
- An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive BladderCompletedNCT02161159
- Study to Evaluate the Effect of Food Upon the Pharmacokinetics of AndroxalCompletedNCT02146391Phase 1
- Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb SpasticityWithdrawnNCT02145689Phase 3
- Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical NeedsWithdrawnNCT02145650
- Comparison of Two Formulations of Proellex for Oral AdministrationCompletedNCT02141061Phase 1
- A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)Active, not recruitingNCT02130362
- Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic ImpairmentCompletedNCT02120547Phase 1
- A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male SubjectsCompletedNCT02117830Phase 1
- Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung CancerCompletedNCT02106546Phase 3
- A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid TumorsActive, not recruitingNCT02099058Phase 1
- Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or PlaceboCompletedNCT02097147Phase 1
- A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's LymphomaWithdrawnNCT02095574Phase 1
- A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell LymphomaWithdrawnNCT02087878
- An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian MedicationsCompletedNCT02082249Phase 3
- An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal MenWithdrawnNCT02082197Phase 3
- Study of Intravenous NRX-1074 in Patients With Major Depressive DisorderCompletedNCT02067793Phase 2
- Bioavailability of ABT-450 and ABT-267 With RitonavirCompletedNCT02052362Phase 1
- Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy SubjectsCompletedNCT02052349Phase 1
- A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid TumorsCompletedNCT02033551Phase 1
- A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast CancerCompletedNCT02032277Phase 3
- Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in KoreaCompletedNCT02010788
- A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid TumorsCompletedNCT02009631Phase 1
- A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%CompletedNCT01993225Phase 3
- A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%CompletedNCT01993212Phase 3
- Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy MalesCompletedNCT01991327Phase 1
- Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland DysfunctionCompletedNCT01979887
- Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in KoreaCompletedNCT01976611
- An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's LymphomaCompletedNCT01969695Phase 1
- A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199WithdrawnNCT01969682Phase 1
- A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199CompletedNCT01969669Phase 1
- A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid TumorsTerminatedNCT01963715Phase 1
- Comparison of Two Formulations of Proellex for Vaginal AdministrationCompletedNCT01962805Phase 1
- Open-Label Extension Study to ZPE-202WithdrawnNCT01961908Phase 2
- Evaluation of Diet and Exercise in Prostate Cancer PatientsCompletedNCT01960881